ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
February 24, 2023 16:20 ET
|
ARCA biopharma, Inc.
WESTMINSTER, Colo., Feb. 24, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted...
Studio City Announces Earnings Release Date
February 24, 2023 08:39 ET
|
Studio City
MACAU, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will release its...
Broadwind Reports Fourth Quarter and Full-Year 2022 Conference Call and Webcast Date
February 23, 2023 18:00 ET
|
Broadwind
CICERO, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN), a diversified precision manufacturer of specialized components and solutions serving global markets, today announced that it...
Visteon Announces 2022 Financial Results and 2023 Outlook
February 16, 2023 06:55 ET
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2022 financial results that exceed its previous outlook....
Visteon to Announce Fourth Quarter and Full-Year 2022 Results on Feb. 16
January 27, 2023 11:00 ET
|
Visteon Corporation
VAN BUREN TOWNSHIP, Mich., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, will release its fourth quarter 2022 and...
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
December 22, 2022 16:00 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022 00:00 ET
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021 Discussions with U.S. FDA progressed regarding both biologic license...
Alvotech kynnir uppgjör fyrir fyrstu níu mánuði ársins 2022 og skýrir frá helstu áföngum í rekstri
November 15, 2022 23:55 ET
|
Alvotech
Tekjur fyrstu níu mánuði ársins voru 8,7 milljarðar króna samanborið við 291 milljón króna á sama tímabili í fyrraViðræður héldu áfram við Bandaríska lyfjaeftirlitið (FDA) um meðferð beggja umsókna um...
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 15, 2022 23:55 ET
|
Alvotech
Revenue for first nine months of 2022 increased to $59.2 million, compared to $2.0 million for the same period in 2021Discussions with U.S. FDA progressed regarding both biologic license applications...
Broadwind Announces Third Quarter 2022 Results
November 08, 2022 07:00 ET
|
Broadwind
CICERO, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Broadwind (NASDAQ: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets, today...